ABBV250509P225000
- 21.77
- 0.000.00%
AbbVie Newsroom
U.S. Pharma Imports Soar in March as Drugmakers Look to Get Ahead of Potential Tariffs
10 Health Care Stocks With Whale Alerts In Today's Session
AbbVie | 10-Q: Quarterly report
Recent Report Shows That Rep. Jefferson Shreve Bought Up to $4.75M Worth of Apple Stock
US, UK to Seek Preferential Treatment on Pharmaceutical Tariffs
FDA to Speed up AI Rollout to Accelerate Drug Reviews
BNP Paribas Exane Adjusts Price Target on AbbVie to $195 From $193, Maintains Neutral Rating
Fund Update: THORNBURG INVESTMENT MANAGEMENT INC Just Disclosed New Holdings
Marjorie Taylor Greene Goes Stock Shopping Again: Here Are 50+ Stocks The Congresswoman Bought
AbbVie Inc. (ABBV): A Bull Case Theory
This House of Representative Just Bought Up To $915K In AbbVie Stock
LLY, VRTX, or ABBV: Which Healthcare Stock Is the Best Pick?
If You Invested $10K In AbbVie Stock 10 Years Ago, How Much Would You Have Now?
Trump Sets Pharma Tariffs Deadline. The Fallout for Lilly, Pfizer, Other Drugmakers
Trump Sets Pharma Tariffs Deadline. The Fallout for Lilly, Pfizer, Other Drugmakers. -- Barrons.com
ChatGPT Stock Advice: AbbVie Inc. (ABBV) Among Top Stock Recommendations
AbbVie to Present at the Bank of America Securities Healthcare Conference
Top Midday Stories: Trump Vows 100% Tariff on Foreign-Made Films; Buffett to Step Down As Berkshire CEO
Why Is Israel-Based Generic Drug Focused Teva Pharmaceutical Stock Trading Higher On Monday?
Market Chatter: India Offers US Reciprocal Zero Tariffs on Steel, Auto Parts, Pharmaceutical Drugs